Related Experiment Video
Updated: Jun 9, 2025

Microfluidic Co-Culture Models for Dissecting the Immune Response in in vitro Tumor Microenvironments
Published on: April 30, 2021
Fusing Artificial Intelligence and Machine Learning for Anti-Cancer Drug Discovery
Christos Adamopoulos1,2, Kostas A Papavassiliou3, Athanasios G Papavassiliou1
1Department of Biological Chemistry, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece.
Artificial intelligence (AI) and machine learning (ML) are revolutionizing oncology, accelerating cancer drug discovery and development. These technologies enhance precision medicine and therapeutic strategies for improved patient outcomes.
Area of Science:
- Oncology
- Computational Biology
- Pharmacology
Background:
- The landscape of cancer drug discovery is being reshaped by advanced computational approaches.
- Artificial intelligence (AI) and machine learning (ML) offer powerful tools for analyzing complex biological data.
More Related Videos
07:40A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
Published on: May 27, 2021
04:09Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
Published on: October 10, 2018
Related Concept Videos
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Tumor Immunotherapy